AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Phenotypic and Genotypic Detection of Biofilm Formation Pseudomonas oryzihabitance and Susceptibility to Antibiotics

Al-Qasim Green University, Veterinary Collage, Department of Microbiology, Iraq
Show Author Information

Abstract

Pseudomonas oryzihabitans is uncommon pathogen, but recently there may be warning of this bacterium to be dangerous, highly virulence, and may cause increase in morbidity and mortality rate, especially if there are multi-drug resistance and biofilm former. Biofilm forming bacteria display resistance to antibiotics, reaching to 1000 time higher than planktonic bacteria. The aim of the current study was to detect Pseudomonas oryzihabitans as biofilm producer and determine the susceptibility to the tested antibiotics. Pseudomonas oryzihabitans was isolated from urine of catheterized patients in Iraqi hospitals and diagnosed as biofilm former phenotypically by congo red and tissue culture plate methods, and genetically by polymerase chain reaction analysis to detect lasR gene (quarm sensing gene) as biofilm indicator and determine its susceptibility to antibiotics by disc diffusion and VITEK AST method. The results revealed that Pseudomonas oryzihabitans was present at 3 isolates; all of them had lasR gene and were resistant to most tested antibiotics at 100%, except that it showed sensitivity rate reaching to 100% to imipenem. From the present study, it was concluded that Pseudomonas oryzihabitans was isolated for the first time as biofilm producer from urinary catheter which possessed lasR gene as biofilm formation indicator, and the multi-drug resistance was considered as a distinctive feature of biofilm formation bacteria.

References

[1]

J. Freney, W. Hansen, J. Etienne, et al., Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2). Journal of Clinical Microbiology, 1988, 26(6): 1241-1243.

[2]

L. Dussart, J.P. Dupont, I. Zimmerlin, et al., Occurrence of sessile Pseudomonas oryzihabitans from a karstified chalk aquifer. Water Research, 2003, 37(7): 1593-1600.

[3]

F. Lejbkowicz, L. Belavsky, R. Kudinsky, et al., Bacteraemia and sinusitis due to Flavimonas oryzihabitans infection. Scandinavian Journal of Infectious Diseases, 2003, 35(6-7): 411-413.

[4]

K.G. Lucas, T.E. Kiehn, K.A. Sobeck, et al., Sepsis caused by Flavimonas oryzihabitans. Medicine, 1994, 73(4): 209-214.

[5]

S.M. Bhatawadekar, Community-acquired urinary tract infection by Pseudomonas oryzihabitans. Journal of Global Infectious Diseases, 2013, 5(2): 82.

[6]

S.M. Jacobsen, D.J. Stickler, H.L. Mobley, et al., Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clinical Microbiology Reviews, 2008, 21(1): 26-59.

[7]

J.R. Johnson, M.A. Kuskowski, and T.J. Wilt, Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Annals of Internal Medicine, 2006, 144(2): 116-126.

[8]

H.S. Joo, M. Otto, Molecular basis of in vivo biofilm formation by bacterial pathogens. Chemistry & Biology, 2012, 19(12): 1503-1513.

[9]

N.K.K. Hindi, S.O. Hasson, and S.K.K. Hindi, Bacteriological study of urinary tract infections with antibiotics susceptibility to bacterial isolates among honeymoon women in Al Qassim Hospital, Babylon Province, Iraq. British Biotechnology Journal, 2013, 3(3): 332-340.

[10]

N.K. Palanisamy, N. Ferina, A.N. Amirulhusni, et al., Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa. Journal of nanobiotechnology, 2014, 12(1): 2.

[11]

L. Zhang, M. Fritsch, L. Hammond, et al., Identification of genes involved in Pseudomonas aeruginosa biofilm-specific resistance to antibiotics. PLoS One, 2013, 8(4): e61625.

[12]

J.K. Hatt, P.N. Rather, Role of bacterial biofilms in urinary tract infections. Curr Top Microbiol Immunol, 2008, 322: 136-192.

[13]

C. Delcaru, I. Alexandru, P. Podgoreanu, et al., Microbial biofilms in urinary tract infections and prostatitis: etiology, pathogenicity, and combating strategies. Pathogens, 2016, 5(4): 65.

[14]
M. Chifiriuc, G. Mihăescu, and V. Lazăr, Medical microbiology and virology. Univ. of Bucharest Publ. House, 2011.
[15]

S. Neethirajan, M.A. Clond, and A. Vogt, Medical biofilms—nanotechnology approaches. Journal of Biomedical Nanotechnology, 2014, 10(10): 2806-2827.

[16]
C. Limban, M.C. Chifiriuc, and A.M. Grumezescu, Thiourea derivatives as antimicrobials: Synthesis, biological activity and potentiation by nanotechnological solutions. LAP Lambert Academic Publishing, 2013.
[17]
J.F. MacFaddin, Biochemical tests for identification of medical bacteria. 3rd ed. Williams and Wilkins. Baltimore, USA, 2000.
[18]
P. Tille, Bailey & Scott's Diagnostic Microbiology-E-Book. Elsevier Health Sciences, 2015.
[19]

D. Freeman, F. Falkiner, and C. Keane, New method for detecting slime production by coagulase negative staphylococci. Journal of Clinical Pathology, 1989, 42(8): 872-874.

[20]

T.D. Kaiser, E.M. Pereira, K.R. Dos Santos, et al., Modification of the Congo red agar method to detect biofilm production by Staphylococcus epidermidis. Diagnostic Microbiology and Infectious Disease, 2013, 75(3): 235-239.

[21]

G.D. Christensen, W.A. Simpson, J.J. Younger, et al., Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. Journal of Clinical Microbiology, 1985, 22(6): 996-1006.

[22]

S. Bose, M. Khodke, S. Basak, et al., Detection of biofilm producing staphylococci: Need of the hour. Journal of Clinical and Diagnostic Research, 2009, 3(6): 1915-1920.

[23]
CLSI, Performance standards for antimicrobial disk susceptibility tests; Approved standard M02/ A12. 12th ed. Clinical and Laboratory Standards Institute, Wayne, PA, 2015.
[24]
CLSI, performance standards for antimicrobial susceptibility testing. M100, . Clinical and Laboratory Standards Institute, Wayne, PA., 2017.
[25]

R.M. Donlan, Biofilms: microbial life on surfaces. Emerging Infectious Diseases, 2002, 8(9): 881.

[26]

J.H. Tabibian, J. Gornbein, A. Heidari, et al., Uropathogens and host characteristics. Journal of Clinical Microbiology, 2008, 46(12): 3980-3986.

[27]

A.L. Flores-Mireles, J.S. Pinkner, M.G. Caparon, et al., EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Science Translational Medicine, 2014, 6(254): 254ra127-254ra127.

[28]

L. Steindler, I. Bertani, L. De Sordi, et al., LasI/R and RhlI/R quorum sensing in a strain of Pseudomonas aeruginosa beneficial to plants. Applied and Environmental Microbiology, 2009, 75(15): 5131-5140.

[29]

R.S. Smith, B.H. Iglewski, P. aeruginosa quorum-sensing systems and virulence. Current Opinion in Microbiology, 2003, 6(1): 56-60.

[30]

M.D. Koutsoudis, D. Tsaltas, T.D. Minogue, et al., Quorum-sensing regulation governs bacterial adhesion, biofilm development, and host colonization in Pantoea stewartii subspecies stewartii. Proceedings of the National Academy of Sciences, 2006, 103(15): 5983-5988.

[31]

W.S. Tan, N.Y. Muhamad Yunos, P.W. Tan, et al., Pantoea sp. isolated from tropical fresh water exhibiting N-acyl homoserine lactone production. The Scientific World Journal, 2014, 2014: 828971.

[32]

B.W. Trautner, R.O. Darouiche, Role of biofilm in catheter-associated urinary tract infection. American Journal of Infection Control, 2004, 32(3): 177-183.

[33]

M.J. Bottomley, E. Muraglia, R. Bazzo, et al., Molecular insights into quorum sensing in the human pathogen P. aeruginosa from the structure of the virulence regulator LasR bound to its autoinducer. Journal of Biological Chemistry, 2007, 282(18): 13592-13600.

[34]

M. Schuster, M. Urbanowski, and E. Greenberg, Promoter specificity in Pseudomonas aeruginosa quorum sensing revealed by DNA binding of purified LasR. Proceedings of the National Academy of Sciences, 2004, 101(45): 15833-15839.

[35]

Z. Ghanbarzadeh Corehtash, A. Khorshidi, F. Firoozeh, et al., Biofilm formation and virulence factors among Pseudomonas aeruginosa isolated from burn patients. Jundishapur Journal of Microbiology, 2015, 8(10): e22345. .

[36]

M. Burmølle, D. Ren, T. Bjarnsholt, et al., Interactions in multispecies biofilms: Do they actually matter? Trends in Microbiology, 2014, 22(2): 84-91.

[37]

R.D. Monds, G.A. O'Toole, The developmental model of microbial biofilms: Ten years of a paradigm up for review. Trends in Microbiology, 2009, 17(2): 73-87.

[38]

J.D. Pozo, R. Patel, The challenge of treating biofilm‐associated bacterial infections. Clinical Pharmacology & Therapeutics, 2007, 82(2): 204-209.

[39]

K. Lewis, Persister cells and the riddle of biofilm survival. Biochemistry (Moscow), 2005, 70(2): 267-274.

[40]

H. Van Acker, P. Van Dijck, and T. Coenye, Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends in Microbiology, 2014, 22(6): 326-333.

[41]

T. Beaudoin, L. Zhang, A.J. Hinz, et al., The biofilm-specific antibiotic resistance gene ndvB is important for expression of ethanol oxidation genes in Pseudomonas aeruginosa biofilms. Journal of bacteriology, 2012, 194(12): 3128-3136.

[42]
J.F. Committee, British national formulary (BNF) 66. Vol. 66. Pharmaceutical Press, 2013.
Nano Biomedicine and Engineering
Pages 11-17
Cite this article:
Hasson SO. Phenotypic and Genotypic Detection of Biofilm Formation Pseudomonas oryzihabitance and Susceptibility to Antibiotics. Nano Biomedicine and Engineering, 2019, 11(1): 11-17. https://doi.org/10.5101/nbe.v11i1.p11-17

803

Views

72

Downloads

2

Crossref

5

Scopus

Altmetrics

Received: 24 August 2018
Accepted: 24 October 2018
Published: 17 January 2019
© Shaimaa Obaid Hasson.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return